Skip to main content

Advertisement

SpringerLink
Log in

Lung Cancer in Women: a Review

  • Women's Health and Lung Disease (A Kumar, Section Editor)
  • Published:
Current Pulmonology Reports Aims and scope Submit manuscript

Abstract

Purpose of Review

Lung cancer is one of the most common and deadliest cancers affecting millions of men and women worldwide. Historically, lung cancer predominantly affects men, but in recent years there have been significant changes in the epidemiology of lung cancer among women. Additionally, further understanding of lung cancer has changed our approach to the diagnosis and management of lung cancer. This article aims to discuss recent changes in lung cancer among women including incidence, mortality, risk factors, diagnosis, staging, treatment, and prognosis.

Recent Findings

The incidence of lung cancer among women is declining overall but at a significantly slower rate compared to men. The implementation of smoking prevention and cessation efforts has decreased the incidence of cigarette smoking of the past 50 years which has revealed other important risk factors for developing lung cancer. Additionally, new algorithms for diagnosis and staging have led to further changes in management strategies for lung cancer.

Summary

Lung cancer among women is a growing concern with incidence rates decreasing significantly slower compared to men. Risk factors such as age, race, socioeconomic status, and geographic locations are becoming more apparent as important variables in the development of lung cancer among women. Lastly, new advancements in diagnosis, staging, and management are likely to result in improved short- and long-term prognosis in patients with lung cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. American Cancer Society. Global Cancer Facts & Figures 4th Edition. Atlanta: American Cancer Society. 2018.

  2. Martín-Sánchez JC, Lunet N, González-Marrón A, Lidón-Moyano C, Matilla-Santander N, Clèries R, et al. Projections in breast and lung cancer mortality among women: a Bayesian analysis of 52 countries worldwide. Cancer Res. 2018;78(15):4436–42.

    Article  PubMed  Google Scholar 

  3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.

    Article  PubMed  Google Scholar 

  4. Society AC. Global Cancer Facts & Figures 2nd Edition. American Cancer Society: Atlanta; 2011.

    Google Scholar 

  5. Society AC. Global Cancer Facts & Figures 3rd Edition. American Cancer Society: Atlanta; 2015.

    Google Scholar 

  6. Barta JA, Powell CA, Wisnivesky JP. Global epidemiology of lung cancer. Ann Glob Health. 2019;85(1):8.

  7. American Cancer Society. Cancer Facts & Figures 2020. Atlanta: American Cancer Society. 2020.

  8. Society AC. Cancer Facts & Figures 2008. American Cancer Society: Atlanta; 2008.

    Google Scholar 

  9. Group USCSW. US. Cancer Statistics Data Visualization Tool, based on 2019 submission data (1999-2017). U.S. Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute; 2020.

  10. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.

    Article  PubMed  Google Scholar 

  11. Hoffmann D, Hoffmann I. The changing cigarette, 1950-1995. J Toxicol Environ Health. 1997;50(4):307–64.

    Article  CAS  PubMed  Google Scholar 

  12. Bade BC, Dela Cruz CS. Lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41(1):1–24.

    Article  PubMed  Google Scholar 

  13. Schroeder SA, Koh HK. Tobacco control 50 years after the 1964 surgeon general’s report. JAMA. 2014;311(2):141–3.

    Article  CAS  PubMed  Google Scholar 

  14. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65(2):87–108.

    Article  PubMed  Google Scholar 

  15. Gallaway MS, Henley SJ, Steele CB, Momin B, Thomas CC, Jamal A, et al. Surveillance for cancers associated with tobacco use - United States, 2010-2014. MMWR Surveill Summ. 2018;67(12):1–42.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Sanford NN, Sher DJ, Xu X, Aizer AA, Mahal BA. Trends in smoking and e-cigarette use among US patients with cancer, 2014-2017. JAMA Oncol. 2019;5(3):426–8.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Jeon J, Holford TR, Levy DT, Feuer EJ, Cao P, Tam J, et al. Smoking and lung cancer mortality in the United States from 2015 to 2065: a comparative modeling approach. Ann Intern Med. 2018;169(10):684–93.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2):74–108.

    Article  PubMed  Google Scholar 

  19. Sun S, Schiller JH, Gazdar AF. Lung cancer in never smokers--a different disease. Nat Rev Cancer. 2007;7(10):778–90.

    Article  CAS  PubMed  Google Scholar 

  20. Thun MJ, Carter BD, Feskanich D, Freedman ND, Prentice R, Lopez AD, et al. 50-year trends in smoking-related mortality in the United States. N Engl J Med. 2013;368(4):351–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  21. Janerich DT, Thompson WD, Varela LR, Greenwald P, Chorost S, Tucci C, et al. Lung cancer and exposure to tobacco smoke in the household. N Engl J Med. 1990;323(10):632–6.

    Article  CAS  PubMed  Google Scholar 

  22. Jha P, Ramasundarahettige C, Landsman V, Rostron B, Thun M, Anderson RN, et al. 21st-century hazards of smoking and benefits of cessation in the United States. N Engl J Med. 2013;368(4):341–50.

    Article  CAS  PubMed  Google Scholar 

  23. Okazaki I, Ishikawa S, Ando W, Sohara Y. Lung adenocarcinoma in never smokers: problems of primary prevention from aspects of susceptible genes and carcinogens. Anticancer Res. 2016;36(12):6207–24.

    Article  CAS  PubMed  Google Scholar 

  24. North CM, Christiani DC. Women and lung cancer: what is new? Semin Thorac Cardiovasc Surg. 2013;25(2):87–94.

    Article  PubMed  Google Scholar 

  25. Tegin G, Mekala HM, Sarai SK, Lippmann S. E-Cigarette toxicity? South Med J. 2018;111(1):35–8.

    Article  CAS  PubMed  Google Scholar 

  26. Dinakar C, O'Connor GT. The health effects of electronic cigarettes. N Engl J Med. 2016;375(14):1372–81.

    Article  PubMed  Google Scholar 

  27. Schoenborn CA, Gindi RM. Electronic cigarette use among adults: United States. NCHS Data Brief. 2014;2015(217):1–8.

    Google Scholar 

  28. Jamal A, Gentzke A, Hu SS, Cullen KA, Apelberg BJ, Homa DM, et al. Tobacco use among middle and high school students - United States, 2011-2016. MMWR Morb Mortal Wkly Rep. 2017;66(23):597–603.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Volkow ND, Baler RD, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014;370(23):2219–27.

    Article  PubMed  PubMed Central  Google Scholar 

  30. Jemal A, Miller KD, Ma J, Siegel RL, Fedewa SA, Islami F, et al. Higher lung cancer incidence in young women than young men in the United States. N Engl J Med. 2018;378(21):1999–2009.

    Article  PubMed  PubMed Central  Google Scholar 

  31. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2018. CA Cancer J Clin. 2018;68(1):7–30.

    Article  PubMed  Google Scholar 

  32. MacRosty CR, Rivera MP. Lung cancer in women: a modern epidemic. Clin Chest Med. 2020;41(1):53–65.

    Article  PubMed  Google Scholar 

  33. Torre LA, Siegel RL, Jemal A. Lung cancer statistics. Adv Exp Med Biol. 2016;893:1–19.

    Article  PubMed  Google Scholar 

  34. Clegg LX, Reichman ME, Miller BA, Hankey BF, Singh GK, Lin YD, et al. Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control. 2009;20(4):417–35.

    Article  PubMed  Google Scholar 

  35. Sidorchuk A, Agardh EE, Aremu O, Hallqvist J, Allebeck P, Moradi T. Socioeconomic differences in lung cancer incidence: a systematic review and meta-analysis. Cancer Causes Control. 2009;20(4):459–71.

    Article  PubMed  Google Scholar 

  36. Pope CA, Burnett RT, Thun MJ, Calle EE, Krewski D, Ito K, et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002;287(9):1132–41.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  37. Bonjour S, Adair-Rohani H, Wolf J, Bruce NG, Mehta S, Prüss-Ustün A, et al. Solid fuel use for household cooking: country and regional estimates for 1980-2010. Environ Health Perspect. 2013;121(7):784–90.

    Article  PubMed  PubMed Central  Google Scholar 

  38. Samet JM. Residential radon and lung cancer: end of the story? J Toxicol Environ Health A. 2006;69(7):527–31.

    Article  CAS  PubMed  Google Scholar 

  39. Lubin JH, Boice JD, Edling C, Hornung RW, Howe GR, Kunz E, et al. Lung cancer in radon-exposed miners and estimation of risk from indoor exposure. J Natl Cancer Inst. 1995;87(11):817–27.

    Article  CAS  PubMed  Google Scholar 

  40. Fingerhut M, Nelson DI, Driscoll T, Concha-Barrientos M, Steenland K, Punnett L, et al. The contribution of occupational risks to the global burden of disease: summary and next steps. Med Lav. 2006;97(2):313–21.

    PubMed  Google Scholar 

  41. Nielsen LS, Bælum J, Rasmussen J, Dahl S, Olsen KE, Albin M, et al. Occupational asbestos exposure and lung cancer--a systematic review of the literature. Arch Environ Occup Health. 2014;69(4):191–206.

    Article  CAS  PubMed  Google Scholar 

  42. Turner MC, Chen Y, Krewski D, Calle EE, Thun MJ. Chronic obstructive pulmonary disease is associated with lung cancer mortality in a prospective study of never smokers. Am J Respir Crit Care Med. 2007;176(3):285–90.

    Article  PubMed  Google Scholar 

  43. Yang P, Sun Z, Krowka MJ, Aubry MC, Bamlet WR, Wampfler JA, et al. Alpha1-antitrypsin deficiency carriers, tobacco smoke, chronic obstructive pulmonary disease, and lung cancer risk. Arch Intern Med. 2008;168(10):1097–103.

    Article  PubMed  PubMed Central  Google Scholar 

  44. Hubbard R, Venn A, Lewis S, Britton J. Lung cancer and cryptogenic fibrosing alveolitis. A population-based cohort study. Am J Respir Crit Care Med. 2000;161(1):5–8.

    Article  CAS  PubMed  Google Scholar 

  45. Cao S, Wendl MC, Wyczalkowski MA, Wylie K, Ye K, Jayasinghe R, et al. Divergent viral presentation among human tumors and adjacent normal tissues. Sci Rep. 2016;6:28294.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  46. Hennig EM, Suo Z, Karlsen F, Holm R, Thoresen S, Nesland JM. HPV positive bronchopulmonary carcinomas in women with previous high-grade cervical intraepithelial neoplasia (CIN III). Acta Oncol. 1999;38(5):639–47.

    Article  CAS  PubMed  Google Scholar 

  47. Cheng YW, Hsieh LL, Lin PP, Chen CP, Chen CY, Lin TS, et al. Gender difference in DNA adduct levels among nonsmoking lung cancer patients. Environ Mol Mutagen. 2001;37(4):304–10.

    Article  CAS  PubMed  Google Scholar 

  48. Zhai K, Ding J, Shi HZ. Author’s reply to “comments on HPV and lung cancer risk: a meta-analysis” [J. Clin. Virol. (in press)]. J Clin Virol. 2015;63:92–3.

    Article  PubMed  Google Scholar 

  49. Zhai K, Ding J, Shi HZ. HPV and lung cancer risk: a meta-analysis. J Clin Virol. 2015;63:84–90.

    Article  PubMed  Google Scholar 

  50. Daley CL, Iseman M. Mycobacterium avium complex and lung cancer: chicken or egg? Both? J Thorac Oncol. 2012;7(9):1329–30.

    Article  PubMed  Google Scholar 

  51. Lande L, Peterson DD, Gogoi R, Daum G, Stampler K, Kwait R, et al. Association between pulmonary mycobacterium avium complex infection and lung cancer. J Thorac Oncol. 2012;7(9):1345–51.

    Article  PubMed  Google Scholar 

  52. Kirk GD, Merlo C, O’ Driscoll P, Mehta SH, Galai N, Vlahov D, et al. HIV infection is associated with an increased risk for lung cancer, independent of smoking. Clin Infect Dis. 2007;45(1):103–10.

    Article  PubMed  Google Scholar 

  53. Whibley C, Pharoah PD, Hollstein M. p53 polymorphisms: cancer implications. Nat Rev Cancer. 2009;9(2):95–107.

    Article  CAS  PubMed  Google Scholar 

  54. Kure EH, Ryberg D, Hewer A, Phillips DH, Skaug V, Baera R, et al. p53 mutations in lung tumours: relationship to gender and lung DNA adduct levels. Carcinogenesis. 1996;17(10):2201–5.

    Article  CAS  PubMed  Google Scholar 

  55. Toyooka S, Tsuda T, Gazdar AF. The TP53 gene, tobacco exposure, and lung cancer. Hum Mutat. 2003;21(3):229–39.

    Article  CAS  PubMed  Google Scholar 

  56. Ahrendt SA, Decker PA, Alawi EA, Zhu Yr YR, Sanchez-Cespedes M, Yang SC, et al. Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung. Cancer. 2001;92(6):1525–30.

    Article  CAS  PubMed  Google Scholar 

  57. Dogan S, Shen R, Ang DC, Johnson ML, D'Angelo SP, Paik PK, et al. Molecular epidemiology of EGFR and KRAS mutations in 3,026 lung adenocarcinomas: higher susceptibility of women to smoking-related KRAS-mutant cancers. Clin Cancer Res. 2012;18(22):6169–77.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  58. Nelson HH, Christiani DC, Mark EJ, Wiencke JK, Wain JC, Kelsey KT. Implications and prognostic value of K-ras mutation for early-stage lung cancer in women. J Natl Cancer Inst. 1999;91(23):2032–8.

    Article  CAS  PubMed  Google Scholar 

  59. Spitz MR, Wei Q, Dong Q, Amos CI, Wu X. Genetic susceptibility to lung cancer: the role of DNA damage and repair. Cancer Epidemiol Biomark Prev. 2003;12(8):689–98.

    CAS  Google Scholar 

  60. Wei Q, Cheng L, Amos CI, Wang LE, Guo Z, Hong WK, et al. Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: a molecular epidemiologic study. J Natl Cancer Inst. 2000;92(21):1764–72.

    Article  CAS  PubMed  Google Scholar 

  61. Jaeger N, Czepielewski RS, Bagatini M, Porto BN, Bonorino C. Neuropeptide gastrin-releasing peptide induces PI3K/reactive oxygen species-dependent migration in lung adenocarcinoma cells. Tumour Biol. 2017;39(3):1010428317694321.

    Article  PubMed  Google Scholar 

  62. Shriver SP, Bourdeau HA, Gubish CT, Tirpak DL, Davis AL, Luketich JD, et al. Sex-specific expression of gastrin-releasing peptide receptor: relationship to smoking history and risk of lung cancer. J Natl Cancer Inst. 2000;92(1):24–33.

    Article  CAS  PubMed  Google Scholar 

  63. Scagliotti GV, Selvaggi G, Novello S, Hirsch FR. The biology of epidermal growth factor receptor in lung cancer. Clin Cancer Res. 2004;10(12 Pt 2):4227 s–32 s.

    Article  CAS  Google Scholar 

  64. Paez JG, Jänne PA, Lee JC, Tracy S, Greulich H, Gabriel S, et al. EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy. Science. 2004;304(5676):1497–500.

    Article  CAS  PubMed  Google Scholar 

  65. Rosell R, Moran T, Queralt C, Porta R, Cardenal F, Camps C, et al. Screening for epidermal growth factor receptor mutations in lung cancer. N Engl J Med. 2009;361(10):958–67.

    Article  CAS  PubMed  Google Scholar 

  66. Westover D, Zugazagoitia J, Cho BC, Lovly CM, Paz-Ares L. Mechanisms of acquired resistance to first- and second-generation EGFR tyrosine kinase inhibitors. Ann Oncol. 2018;29(suppl_1):i10–i9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  67. Aberle DR, Adams AM, Berg CD, Black WC, Clapp JD, Fagerstrom RM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med. 2011;365(5):395–409.

    Article  PubMed  Google Scholar 

  68. Battafarano RJ, Piccirillo JF, Meyers BF, Hsu HS, Guthrie TJ, Cooper JD, et al. Impact of comorbidity on survival after surgical resection in patients with stage I non-small cell lung cancer. J Thorac Cardiovasc Surg. 2002;123(2):280–7.

    Article  PubMed  Google Scholar 

  69. Sculier JP, Chansky K, Crowley JJ, Van Meerbeeck J, Goldstraw P. Institutions ISCaP. The impact of additional prognostic factors on survival and their relationship with the anatomical extent of disease expressed by the 6th edition of the TNM classification of malignant tumors and the proposals for the 7th edition. J Thorac Oncol. 2008;3(5):457–66.

    Article  PubMed  Google Scholar 

  70. Wisnivesky JP, Halm EA. Sex differences in lung cancer survival: do tumors behave differently in elderly women? J Clin Oncol. 2007;25(13):1705–12.

    Article  PubMed  Google Scholar 

  71. Wheatley-Price P, Blackhall F, Lee SM, Ma C, Ashcroft L, Jitlal M, et al. The influence of sex and histology on outcomes in non-small-cell lung cancer: a pooled analysis of five randomized trials. Ann Oncol. 2010;21(10):2023–8.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Divisions of Critical Care, Pulmonary and Sleep Medicine, McGovern Medical School, UTHealth – The University of Texas at Houston, 6431 Fannin St, MSB 1.434, Houston, TX, 77030, USA

    Alberto A. Goizueta, Rosa M. Estrada-Y-Martin & Sujith V. Cherian

Authors
  1. Alberto A. Goizueta
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Rosa M. Estrada-Y-Martin
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sujith V. Cherian
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sujith V. Cherian.

Ethics declarations

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Conflict of Interest

Sujith Cherian, Alberto Goizueta, and Rosa Estrada-Y-Martin declare no conflict of interest.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

This article is part of the Topical Collection on Women's Health and Lung Disease

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Goizueta, A.A., Estrada-Y-Martin, R.M. & Cherian, S.V. Lung Cancer in Women: a Review. Curr Pulmonol Rep 10, 53–61 (2021). https://doi.org/10.1007/s13665-021-00270-6

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13665-021-00270-6

Keywords

Search

Navigation